{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:49Z","timestamp":1790096929855,"version":"4.0.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1378\/chest.123.4.1254","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1254-1265","source":"Crossref","is-referenced-by-count":44,"title":["Alternate Treatments in Asthma"],"prefix":"10.1016","volume":"123","author":[{"given":"Alexander S.","family":"Niven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Argyros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.4.1254_bib1","series-title":"Guidelines for the diagnosis and management of asthma. NIH Publication No. 98\u20134051","first-page":"59","author":"National Institutes of Health\/National Heart, Lung, and Blood Institute","year":"1999"},{"key":"10.1378\/chest.123.4.1254_bib2","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1067\/mai.2001.116434","article-title":"Experiences with monoclonal antibody therapy for allergic asthma","volume":"108","author":"Boushey","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1067\/mai.2001.113759","article-title":"IgE regulation and roles in asthma pathogenesis","volume":"107","author":"Oettgen","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0889-8561(05)70170-3","article-title":"Novel immunotherapeutic approaches for the treatment of allergic diseases","volume":"20","author":"Mohapatra","year":"2000","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1378\/chest.123.4.1254_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1378\/chest.103.6.1662","article-title":"Difficult-to-control asthma: contributing factors and outcome of a systematic management protocol","volume":"103","author":"Irwin","year":"1993","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0091-6749(78)90052-0","article-title":"Sinus disease in children with respiratory disease","volume":"61","author":"Rachelefsky","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.73.4.526","article-title":"Chronic sinus disease with associated reactive airway disease in children","volume":"73","author":"Rachelefsky","year":"1984","journal-title":"Pediatrics"},{"key":"10.1378\/chest.123.4.1254_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0889-8561(05)70228-9","article-title":"Steroid-resistant asthma","volume":"21","author":"Spahn","year":"2001","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1378\/chest.123.4.1254_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/ajrccm.158.3.9711092","article-title":"Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma","volume":"158","author":"Kraft","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/JAS-120002199","article-title":"Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma","volume":"39","author":"Ekici","year":"2002","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib11","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","article-title":"Mycoplasma pneumoniae, and Chlamydia pneumoniae in asthma: effect of clarithromycin","volume":"121","author":"Kraft","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-69-3-493","article-title":"Steroid resistance in bronchial asthma","volume":"69","author":"Schwartz","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.4.1254_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0091-6749(98)70165-4","article-title":"Difficult-to-control asthma: clinical characteristics of steroid insensitive asthma","volume":"101","author":"Chan","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib14","first-page":"9","article-title":"Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a","volume":"14","author":"Suarez","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.123.4.1254_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00918968","article-title":"Molecular mechanism of methotrexate action in inflammation","volume":"16","author":"Cronstein","year":"1992","journal-title":"Inflammation"},{"key":"10.1378\/chest.123.4.1254_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1164\/ajrccm.155.2.9032171","article-title":"Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders","volume":"155","author":"Lynch","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib17","first-page":"65","article-title":"The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients","volume":"12","author":"Tsai","year":"1994","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1378\/chest.123.4.1254_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/j.1875-9114.1992.tb04476.x","article-title":"Pharmacokinetics of low-dose methotrexate in adult asthmatics","volume":"12","author":"Glynn-Barmhart","year":"1992","journal-title":"Pharmacotherapy"},{"key":"10.1378\/chest.123.4.1254_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1034\/j.1399-3003.2000.15.09.x","article-title":"Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T-cell proliferation","volume":"15","author":"Vrugt","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM198803103181004","article-title":"Methotrexate in the treatment of corticosteroid dependent asthma","volume":"318","author":"Mullarkey","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.4.1254_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(90)91659-X","article-title":"Randomized, double-blind, placebo controlled trial of methotrexate in steroid dependent asthma","volume":"336","author":"Shiner","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.123.4.1254_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-114-5-353","article-title":"Lack of benefit of methotrexate in severe, steroid-dependent asthma","volume":"114","author":"Erzurum","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.4.1254_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0091-6749(91)90330-Q","article-title":"Methotrexate in the treatment of steroid-dependent asthma","volume":"88","author":"Dyer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0954-6111(93)90094-G","article-title":"Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over study","volume":"87","author":"Trigg","year":"1993","journal-title":"Respir Med"},{"key":"10.1378\/chest.123.4.1254_bib26","first-page":"409","article-title":"Methotrexate in the management of severe steroid-dependent asthma","volume":"106","author":"Taylor","year":"1993","journal-title":"N Z Med J"},{"key":"10.1378\/chest.123.4.1254_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0091-6749(94)90204-6","article-title":"Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticoid-dependent asthma","volume":"94","author":"Stewart","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1378\/chest.105.1.117","article-title":"The role of methotrexate in the management of steroid-dependent asthma","volume":"105","author":"Coffey","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00181874","article-title":"Short term effects of methotrexate in severe steroid-dependent asthma","volume":"173","author":"Kanzow","year":"1995","journal-title":"Lung"},{"key":"10.1378\/chest.123.4.1254_bib30","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1164\/ajrccm.152.5.7582277","article-title":"Single, high-dose intramuscular triamcinolone acetonide vs weekly oral methotrexate in life-threatening asthma: a double-blind study","volume":"152","author":"Ogirala","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00203775","article-title":"Controlled trial of methotrexate in patients with severe chronic asthma","volume":"49","author":"Hedman","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.123.4.1254_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1378\/chest.112.1.29","article-title":"Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis","volume":"112","author":"Marin","year":"1997","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0954-6111(98)90355-9","article-title":"Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials","volume":"92","author":"Aaron","year":"1998","journal-title":"Respir Med"},{"key":"10.1378\/chest.123.4.1254_bib34","series-title":"The Cochrane Library, Issue 4","article-title":"Methotrexate as a steroid sparing agent for asthma in adults (Cochrane Review)","author":"Davies","year":"2000"},{"key":"10.1378\/chest.123.4.1254_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-112-8-577","article-title":"Long-term methotrexate treatment in corticosteroid-dependent asthma","volume":"112","author":"Mullarkey","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.4.1254_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1398-9995.1994.tb01130.x","article-title":"Methotrexate in steroid-dependent asthma: long-term results","volume":"49","author":"Shiner","year":"1994","journal-title":"Allergy"},{"key":"10.1378\/chest.123.4.1254_bib37","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0140-6736(92)91325-3","article-title":"Fatal pneumocystis pneumonia in an asthmatic patient treated with methotrexate [letter]","volume":"339","author":"Vallerand","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.123.4.1254_bib38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/thx.46.12.936","article-title":"Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma","volume":"46","author":"Kuitert","year":"1991","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/thx.50.11.1221","article-title":"Fatal varicella zoster infection in a severe steroid dependent asthmatic patient receiving methotrexate","volume":"50","author":"Morice","year":"1995","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm\/143.1.179","article-title":"Methotrexate-induced asthma","volume":"143","author":"Jones","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/ajrccm\/145.3.733","article-title":"Methotrexate: does it treat or induce asthma?","volume":"145","author":"Chung","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-6749(74)90027-X","article-title":"Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis","volume":"54","author":"Spector","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0091-6749(78)90088-X","article-title":"Enhancement by oleandomycin of the inhibitory effect of methylprednisolone on phytohemagglutinin-stimulated lymphocytes","volume":"62","author":"Ong","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-6749(80)90004-4","article-title":"The effect of troleandomycin on methylprednisolone elimination","volume":"66","author":"Szefler","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib45","series-title":"Metabolic effects of macrolide antibiotics on bronchial asthma, experimental anaphylaxis and corticosteroid metabolism: Ninth International Congress of Allergy (vol 144)","first-page":"90","author":"Townley","year":"1967"},{"key":"10.1378\/chest.123.4.1254_bib46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0021-8707(70)90124-3","article-title":"The use of macrolide antibiotic substances in the treatment of asthma","volume":"45","author":"Itkin","year":"1970","journal-title":"J Allergy"},{"key":"10.1378\/chest.123.4.1254_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(93)90010-D","article-title":"Troleandomycin in the treatment of difficult asthma","volume":"92","author":"Siracusa","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0091-6749(80)90003-2","article-title":"Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma","volume":"66","author":"Zeiger","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0091-6749(86)90112-0","article-title":"An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma","volume":"78","author":"Wald","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm\/147.2.398","article-title":"A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids","volume":"147","author":"Nelson","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib51","first-page":"297","article-title":"Hepatic abnormalities associated with long-term use of troleandomycin in asthma: a case report","volume":"41","author":"Dasgupta","year":"1978","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.123.4.1254_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0168-8278(87)80541-X","article-title":"Prolonged cholestasis after troleandomycin-induced acute hepatitis","volume":"4","author":"Larrey","year":"1987","journal-title":"J Hepatol"},{"key":"10.1378\/chest.123.4.1254_bib53","first-page":"61","article-title":"Troleandomycin hepatotoxicity: a case report of overt jaundice and a placebo-controlled trial","volume":"48","author":"Uzzan","year":"1993","journal-title":"Therapie"},{"key":"10.1378\/chest.123.4.1254_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0889-8561(05)70271-X","article-title":"Treatment of steroid-resistant asthma","volume":"16","author":"Ledford","year":"1996","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1378\/chest.123.4.1254_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","article-title":"Biologic actions and pharmacodynamic studies of auranofin","volume":"75","author":"Walz","year":"1983","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.4.1254_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01987994","article-title":"Modulation of the release of histamine and aracidonic acid metabolites from human basophils and mast cells by auranofin","volume":"18","author":"Marone","year":"1986","journal-title":"Agents Actions"},{"key":"10.1378\/chest.123.4.1254_bib57","first-page":"47","article-title":"Effects of gold compounds on leukotriene B4, leukotriene C4 and prostaglandin E2 production by polymorphonuclear leukocytes","volume":"3","author":"Parente","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.123.4.1254_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(88)90213-8","article-title":"An open study of auranofin in the treatment of steroid-dependent asthma","volume":"81","author":"Bernstein","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-6749(95)70015-3","article-title":"Gold sodium thiomalate selectively inhibits interleukin-5-mediated eosinophil survival","volume":"96","author":"Suzuki","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/02770909209110635","article-title":"Alternative therapy in severe asthma","volume":"29","author":"Alvarez","year":"1992","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/thx.49.7.649","article-title":"Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma","volume":"49","author":"Honoma","year":"1994","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0091-6749(87)90202-8","article-title":"Chrysotherapy in the treatment of steroid-dependent asthma","volume":"79","author":"Klaustermeyer","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib63","first-page":"132","article-title":"Gold salt in the treatment of bronchial asthma: a double blind study","volume":"40","author":"Muranaka","year":"1978","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.123.4.1254_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thx.47.5.349","article-title":"Auranofin in the treatment of steroid dependent asthma: a double blind study","volume":"47","author":"Nierop","year":"1992","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-6749(96)70156-2","article-title":"A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma: Auranofin Multicenter Drug Trial","volume":"98","author":"Bernstein","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.52.5.447","article-title":"Effect of cyclosporin A on the allergen-induced late asthmatic reaction","volume":"52","author":"Sihra","year":"1997","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mai.2001.115758","article-title":"Alternative agents in asthma","volume":"108","author":"Frew","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1183\/09031936.95.08040574","article-title":"Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations","volume":"8","author":"Alexander","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1183\/09031936.95.08091473","article-title":"FK506, and cyclosporin A inhibit granulocyte\/macrophage colony-stimulating factor production by mononuclear cells in asthma","volume":"8","author":"Sano","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib70","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/intimm\/7.3.449","article-title":"IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporine A","volume":"7","author":"Mori","year":"1995","journal-title":"Int Immunol"},{"key":"10.1378\/chest.123.4.1254_bib71","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.162.4.9911117","article-title":"Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor and eotaxin","volume":"162","author":"Khan","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib72","first-page":"65","article-title":"Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma","volume":"75","author":"Fukuda","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1378\/chest.123.4.1254_bib73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0140-6736(92)91646-P","article-title":"Trial of cyclosporin in corticosteroid-dependent chronic severe asthma","volume":"339","author":"Alexander","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.123.4.1254_bib74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/ajrccm.153.2.8564089","article-title":"Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma","volume":"153","author":"Lock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib75","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.95.08071091","article-title":"Treatment of steroid-dependent bronchial asthma with cyclosporin","volume":"8","author":"Nizankowska","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib76","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1991.tb00590.x","article-title":"Cyclosporin for steroid-dependent asthma","volume":"46","author":"Szczeklik","year":"1991","journal-title":"Allergy"},{"key":"10.1378\/chest.123.4.1254_bib77","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0091-6749(91)90420-S","article-title":"An open-label study of high dose intravenous immunoglobulin in severe childhood asthma","volume":"87","author":"Mazer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/clin.1994.1186","article-title":"Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin","volume":"73","author":"Amran","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1378\/chest.123.4.1254_bib79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI112835","article-title":"Reversal of immunoregulatory abnormalities in Kawasaki syndrome by intravenous gammaglobulin","volume":"79","author":"Leung","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.123.4.1254_bib80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(99)70466-5","article-title":"Mechanisms of glucocorticoid reductions in asthmatic patients treated with intravenous immunoglobulin","volume":"103","author":"Spahn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.1994.tb00833.x","article-title":"Slight steroid-sparing effects of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma","volume":"49","author":"Jakobsson","year":"1994","journal-title":"Allergy"},{"key":"10.1378\/chest.123.4.1254_bib82","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1378\/chest.114.5.1349","article-title":"Benefits of high-dose IV immunoglobulin in patients with severe steroid-dependent asthma","volume":"114","author":"Landwehr","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib83","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0091-6749(99)70424-0","article-title":"Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial","volume":"103","author":"Salmun","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/clim.1999.4714","article-title":"A multi-center, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma","volume":"91","author":"Kishiyama","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib85","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-3623(94)00170-R","article-title":"Heparin: pharmacological potentials from atherosclerosis to asthma","volume":"26","author":"Ragazzi","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1378\/chest.123.4.1254_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0091-6749(83)90056-8","article-title":"The plasma contact system in atopic asthma","volume":"72","author":"Lasser","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib87","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1398-9995.1987.tb00393.x","article-title":"Heparin-like anticoagulants in asthma","volume":"42","author":"Lasser","year":"1987","journal-title":"Allergy"},{"key":"10.1378\/chest.123.4.1254_bib88","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/ajrccm\/139.3.801","article-title":"Toxicity of eosinophil cationic protein from guinea-pig tracheal epithelium in vitro","volume":"139","author":"Motojima","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib89","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.1074\/jbc.273.22.13563","article-title":"Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma","volume":"273","author":"Fath","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1378\/chest.123.4.1254_bib90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/eji.1830200306","article-title":"Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity","volume":"20","author":"Lider","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1378\/chest.123.4.1254_bib91","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1661157","article-title":"The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis","volume":"52","author":"Matzner","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.123.4.1254_bib92","series-title":"Airways and vascular remodeling in asthma and cardiovascular disease: implications for therapeutic intervention","first-page":"45","article-title":"Heparin\/heparin sulphate regulation of vascular smooth muscle behavior","author":"Karnovsky","year":"1994"},{"key":"10.1378\/chest.123.4.1254_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0192-0561(86)90109-8","article-title":"Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions","volume":"8","author":"Ekre","year":"1986","journal-title":"Int J Immunopharmacol"},{"key":"10.1378\/chest.123.4.1254_bib94","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/jappl.1994.76.2.893","article-title":"Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation","volume":"76","author":"Ahmed","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.123.4.1254_bib95","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1288\/00005537-196007000-00001","article-title":"The use of heparin as an anti-inflammatory agent","volume":"70","author":"Dolowitz","year":"1960","journal-title":"Laryngoscope"},{"key":"10.1378\/chest.123.4.1254_bib96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9149(64)90100-6","article-title":"Heparin in the treatment of chronic obstructive bronchopulmonary disease","volume":"14","author":"Boyle","year":"1964","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.123.4.1254_bib97","first-page":"886","article-title":"Objective evaluation of heparin in the treatment of asthma","volume":"98","author":"Fine","year":"1968","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib98","first-page":"108","article-title":"Heparin as treatment for bronchospasm in asthma","volume":"27","author":"Bardana","year":"1969","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.123.4.1254_bib99","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/ajrccm\/145.3.566","article-title":"Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep","volume":"145","author":"Ahmed","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199307083290204","article-title":"Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin","volume":"329","author":"Ahmed","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.4.1254_bib101","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1164\/ajrccm.153.5.8630624","article-title":"Time course of the protective effect of inhaled heparin on exercise-induced asthma","volume":"153","author":"Garrigo","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib102","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/ajrccm.160.2.9812076","article-title":"Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin","volume":"160","author":"Ahmed","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib103","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/ajrccm\/147.1.160","article-title":"Heparin inhibits the immediate response to antigen in the skin and lungs of allergic patients","volume":"147","author":"Bowler","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib104","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1164\/ajrccm.153.6.8665036","article-title":"Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma","volume":"153","author":"Diamant","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.4.1254_bib105","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.107.4.1009","article-title":"Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity","volume":"107","author":"Ceyhan","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/02770909709067224","article-title":"Effect of pretreatment with heparin on pulmonary and cutaneous response","volume":"34","author":"Kalpaklioglu","year":"1997","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.96.09020217","article-title":"The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma","volume":"9","author":"Pavord","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/rmed.1999.0677","article-title":"Inhaled heparin is effective in exacerbations of asthma","volume":"94","author":"Bendstrup","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.123.4.1254_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(88)92540-8","article-title":"Prevention of exercise-induced bronchoconstriction by inhaled frusemide","volume":"2","author":"Bianco","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.123.4.1254_bib110","first-page":"218","article-title":"Inhibition of chloride secretion by furosemide in canine tracheal epithelium","volume":"71","author":"Welsh","year":"1993","journal-title":"J Membr Biol"},{"key":"10.1378\/chest.123.4.1254_bib111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/ajrcmb.14.4.8600943","article-title":"Asthma prophylaxis agents alter the function of an airway epithelial chloride channel","volume":"14","author":"Alton","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1378\/chest.123.4.1254_bib112","first-page":"481","article-title":"Effect of anion transport inhibitors and extracellular Cl-concentrations on eosinophil respiratory burst activity","volume":"107","author":"Perkins","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1378\/chest.123.4.1254_bib113","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1164\/ajrccm\/143.6.1340","article-title":"Loop diuretics inhibit cholinergic and non-cholinergic nerves in guinea pig airways","volume":"143","author":"Elwood","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJM199101103240218","article-title":"Inhibition by furosemide of inflammatory mediators from lung fragments [letter]","volume":"324","author":"Anderson","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.4.1254_bib115","first-page":"1155","article-title":"Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop","volume":"251","author":"Miyanoshita","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.123.4.1254_bib116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/thx.48.3.195","article-title":"Diuretics and asthma","volume":"48","author":"Barnes","year":"1993","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib117","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/ajrcmb.10.4.8136154","article-title":"Effect of furosemide on prostaglandin synthesis by human nasal and bronchial epithelial cells in culture","volume":"10","author":"Levasseur-Acker","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1378\/chest.123.4.1254_bib118","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/thx.47.10.797","article-title":"Inhaled furosemide and exercise induced asthma: evidence of a role for inhibitory prostanoids","volume":"47","author":"Pavord","year":"1992","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/thx.49.4.307","article-title":"Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products","volume":"49","author":"O'Connor","year":"1994","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/jappl.1994.76.1.409","article-title":"Inhaled furosemide attenuates hyperpnea-induced obstruction and intra-airway thermal gradients","volume":"76","author":"Gilbert","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.123.4.1254_bib121","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1152\/jappl.1996.81.6.2461","article-title":"Effect of furosemide on hyperpnea-induced airway obstruction, injury, and microvascular leakage","volume":"81","author":"Freed","year":"1996","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.123.4.1254_bib122","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1183\/09031936.96.09040716","article-title":"Mucociliatory clearance during and after isocapnic hyperventilation with dry air in the presence of frusemide","volume":"9","author":"Daviskas","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib123","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1183\/09031936.94.07081497","article-title":"Inhaled frusemide does not affect lung mucociliary clearance in health and asthmatic subjects","volume":"7","author":"Hasani","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib124","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM198910193211602","article-title":"Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions","volume":"321","author":"Bianco","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.4.1254_bib125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/ajrccm\/143.3.561","article-title":"Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic \u201cfog\u201d of distilled water in asthmatics","volume":"143","author":"Moscato","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib126","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1164\/ajrccm\/143.6.1329","article-title":"Effect of inhaled furosemide and bumetanide on adenosine 5\u2032-monophosphate- and sodium metabisulfate-induced bronchoconstriction in asthmatic subjects","volume":"143","author":"O'Conner","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib127","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/ajrccm\/142.3.576","article-title":"Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects","volume":"142","author":"Nichol","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib128","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1378\/chest.102.2.408","article-title":"Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects","volume":"102","author":"Vargas","year":"1992","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/thx.52.10.861","article-title":"Attenuation of propranolol-induced bronchoconstriction by furosemide","volume":"52","author":"Myers","year":"1997","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib130","first-page":"85","article-title":"Inhaled furosemide does not alter the bronchial response to methacholine in asthmatics [abstract]","volume":"1","author":"Vaghi","year":"1988","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.123.4.1254_bib131","first-page":"A548","article-title":"Frusemide inhibits cough but not bronchoconstriction to prostaglandin F2\u03b1 in patients with asthma [abstract]","volume":"143","author":"Stone","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib133","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1081-1206(10)63395-9","article-title":"Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects","volume":"78","author":"Siffredi","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1378\/chest.123.4.1254_bib134","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/ajrccm\/142.1.143","article-title":"Inhaled frusemide inhibits cough induced by low-chloride solutions but not by capsaicin","volume":"142","author":"Ventresca","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.4.1254_bib135","first-page":"752P","article-title":"Effect of frusemide on cough response to low-chloride solution in subjects with mild asthma [abstract]","volume":"46","author":"Stone","year":"1991","journal-title":"Thorax"},{"key":"10.1378\/chest.123.4.1254_bib136","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/02770909409044810","article-title":"Furosemide and other diuretics in asthma","volume":"31","author":"Chung","year":"1994","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib137","series-title":"Respiratory allergy","first-page":"261","article-title":"Steroid sparing effect of inhaled lysine-aspirin and furosemide in steroid-dependent asthma","author":"Bianco","year":"1993"},{"key":"10.1378\/chest.123.4.1254_bib138","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0091-6749(95)70092-7","article-title":"Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma","volume":"95","author":"Bianco","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.123.4.1254_bib139","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1378\/chest.106.5.1396","article-title":"Inhaled furosemide is not effective in acute asthma","volume":"106","author":"Karpel","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.123.4.1254_bib140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/02770909809055409","article-title":"Effect of inhaled furosemide in acute asthma","volume":"35","author":"Pendino","year":"1998","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib141","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/02770909709067218","article-title":"Furosemide given by inhalation ameliorates acute exacerbations of asthma","volume":"34","author":"Ono","year":"1997","journal-title":"J Asthma"},{"key":"10.1378\/chest.123.4.1254_bib142","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000196652","article-title":"Rapid response to inhaled frusemide in severe acute asthma with hypercapnia","volume":"64","author":"Tanigaki","year":"1997","journal-title":"Respiration"},{"key":"10.1378\/chest.123.4.1254_bib20","first-page":"347","article-title":"Methotrexate in the treatment of steroid dependent asthma","volume":"56","author":"Mullarkey","year":"1986","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.123.4.1254_bib132","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1183\/09031936.93.06060862","article-title":"Effect of frusemide on cough responses to chloride-deficient solution in normal and mild asthmatic subjects","volume":"6","author":"Stone","year":"1993","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215325435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215325435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:09:58Z","timestamp":1734041398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215325435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0012369215325435"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.4.1254","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}